Postpartum Haemorrhage Treatment Device Market Size 2031
The Postpartum Haemorrhage Treatment Device Market is expected to register a CAGR of 5.4% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Product Type (Non-Pneumatic Anti-Shock Garment, Prefilled Injection System, and Uterine Tamponade Devices), End Users (Hospitals, Clinics, and Other End Users)
Purpose of the ReportThe report Postpartum Haemorrhage Treatment Device Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Postpartum Haemorrhage Treatment Device Market Segmentation
Product Type- Non-Pneumatic Anti-Shock Garment
- Prefilled Injection System
- Uterine Tamponade Devices
- Hospitals
- Clinics
- Other End Users
Strategic Insights
Postpartum Haemorrhage Treatment Device Market Growth Drivers- Rising Incidence of Postpartum Hemorrhage (PPH): One of the foremost reasons why the market is induced is the rise in cases of postpartum hemorrhage (PPH) especially in developing countries where there are poor maternal health care services. Advanced maternal age, more than one pregnancy, and elective C-sections are some of the reasons paving way for increased instances of PPH. This concern in the healthcare issues increases the need for specialized treatment devices including intrauterine ballons and topical hemostatic agents to curb the deaths associated with the condition.
- Technological Advancements in Hemostatic Devices: Improvements in hemostatic devices such as pressure transducing uterine balloons and energy devices for bleeding control have a positive impact on the postpartum hemorrhage treatment device market. These modern apparatuses are quick to use by the clinicians for the management of PPH due to their gentle non-intrusive nature and ease of use hence reducing the complications and improving patient care. There is thus a growing scope of the market.
- Focus on Maternal Health in Global Healthcare Initiatives: Another key factor propelling the postpartum hemorrhage treatment device market is the shifting trends towards enhancing maternal health outcomes especially in the health systems of the developing countries. There are governmental, non-governmental as well as international agencies which are concerned with prevention of maternal mortality, and postpartum hemorrhage in particular. This has resulted in increased use of treatment systems and procedures in the hospitals and clinics, which has resulted in increase in the market.
- Shift Towards Minimally Invasive Devices: One of the most growing trends in the postpartum hemorrhage (PPH) treatment device market is the trend towards less invasive options. Uterine balloon tamponades and other similar devices have been developed that help control the hemorrhage with less surgery. These systems lower risks, fasten the process of healing, and provide alternative methods of constraining PPH which are safer, hence are preferred more in both advanced and low resource areas clinically.
- Integration of Smart Monitoring and Data Analytics: In postpartum hemorrhage treatment devices, yet another trend that is emerging is the use of smart technology and data. More advanced, sensor-monitored devices provide instant results on the levels of uterine contraction, bleeding estimations, and other vitals of the patient. Such technologies not only assists in better medication management, evaluation of the intervention’s efficiency but also helps in better maternal care advancing these devices.
- Focus on Preventive and Prophylactic Devices: It has been noted that there is an increasing concern in the development and manufacture of such devices to prevent postpartum hemorrhage. Such devices that assist in controlling bleeding, especially up to child birth or right after delivery, are being sought to become part of normal birthing processes. Other developments are proactive measures such as those that aim at correcting the situation before it arises, these include the early warning device and also the uterine compression device in high risk pregnancies or for women that have primary postpartum hemorrhage (PPH).
- Expansion in Emerging Markets: The market for devices used to treat postpartum hemorrhage (PPH) has high prospects for development in developing countries, which have high maternal mortality rates owing to little access to modern medical devices. Since there has been an improvement in the health care system in the Asia-Pacific, African and Latin American regions, there will be increased demand for affordable and available device for the treatment of PPH, which creates an avenue for the growth of the market and a reach to unserviced countries.
- Increased Focus on Maternal Health Programs: The PPH treatment device market has ample scope due to worldwide efforts aimed at improving the health of women. Due to bodies like WHO informing that there is need to curb maternal morbidity and mortality, the wanting of advanced and dynamic PPH devices will be on the rise. This could be further enhanced by the low-cost Dunbar devices for low fruition centers.
- Development of Personalized PPH Treatment Devices: With the widespread acceptance of the concept of personalized medicine, the opportunity to design a retrospective PPH treatment device is also coming in the way. For instance, such a device may also consider the uterine tone, degree of bleeding, and patient’s co morbid conditions. Therefore, innovations and treatment strategies that focus on precision medicine seem to be promising in preventing and managing PPH and would improve maternal health, open avenues for development and market.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Postpartum Haemorrhage Treatment Device Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Postpartum Haemorrhage Treatment Device Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The postpartum haemorrhage treatment device market is estimated to grow with a CAGR of 5.4% from 2023 to 2031.
Asia Pacific region is likely to witness fastest growth rate during the forecast period.
The postpartum haemorrhage treatment device market majorly consists of the players such as Cook Medical, BD, Utah Medical Products, Inc among others.
Shift towards minimally invasive devices are likely to remain the key trend during the forecast period
The market drivers include rising incidence of postpartum hemorrhage (PPH) and technological advancements in hemostatic devices are driving the postpartum haemorrhage treatment device market
North America dominated the postpartum haemorrhage treatment device market in 2023
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Postpartum Haemorrhage Treatment Device Market - By Product
1.3.2 Postpartum Haemorrhage Treatment Device Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. POSTPARTUM HAEMORRHAGE TREATMENT DEVICE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. POSTPARTUM HAEMORRHAGE TREATMENT DEVICE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. POSTPARTUM HAEMORRHAGE TREATMENT DEVICE MARKET - GLOBAL MARKET ANALYSIS
6.1. POSTPARTUM HAEMORRHAGE TREATMENT DEVICE - GLOBAL MARKET OVERVIEW
6.2. POSTPARTUM HAEMORRHAGE TREATMENT DEVICE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. POSTPARTUM HAEMORRHAGE TREATMENT DEVICE MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. NON-PNEUMATIC ANTI-SHOCK GARMENT
7.3.1. Overview
7.3.2. Non-Pneumatic Anti-Shock Garment Market Forecast and Analysis
7.4. UNIJECT PREFILLED INJECTION SYSTEM
7.4.1. Overview
7.4.2. Uniject Prefilled Injection System Market Forecast and Analysis
7.5. UTERINE BALLOON TAMPONADE
7.5.1. Overview
7.5.2. Uterine Balloon Tamponade Market Forecast and Analysis
7.5.3. Foley Catheter Market
7.5.3.1. Overview
7.5.3.2. Foley Catheter Market Forecast and Analysis
7.5.4. Bakri Balloon Tamponade Market
7.5.4.1. Overview
7.5.4.2. Bakri Balloon Tamponade Market Forecast and Analysis
7.5.5. BT-Cath Balloon Market
7.5.5.1. Overview
7.5.5.2. BT-Cath Balloon Market Forecast and Analysis
7.5.6. Rusch Balloon. Market
7.5.6.1. Overview
7.5.6.2. Rusch Balloon. Market Forecast and Analysis
8. POSTPARTUM HAEMORRHAGE TREATMENT DEVICE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Postpartum Haemorrhage Treatment Device Market Overview
8.1.2 North America Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis
8.1.3 North America Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis - By Product
8.1.4 North America Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis - By Countries
8.1.4.1 United States Postpartum Haemorrhage Treatment Device Market
8.1.4.1.1 United States Postpartum Haemorrhage Treatment Device Market by Product
8.1.4.2 Canada Postpartum Haemorrhage Treatment Device Market
8.1.4.2.1 Canada Postpartum Haemorrhage Treatment Device Market by Product
8.1.4.3 Mexico Postpartum Haemorrhage Treatment Device Market
8.1.4.3.1 Mexico Postpartum Haemorrhage Treatment Device Market by Product
8.2. EUROPE
8.2.1 Europe Postpartum Haemorrhage Treatment Device Market Overview
8.2.2 Europe Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis
8.2.3 Europe Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis - By Product
8.2.4 Europe Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Postpartum Haemorrhage Treatment Device Market
8.2.4.1.1 Germany Postpartum Haemorrhage Treatment Device Market by Product
8.2.4.2 France Postpartum Haemorrhage Treatment Device Market
8.2.4.2.1 France Postpartum Haemorrhage Treatment Device Market by Product
8.2.4.3 Italy Postpartum Haemorrhage Treatment Device Market
8.2.4.3.1 Italy Postpartum Haemorrhage Treatment Device Market by Product
8.2.4.4 Spain Postpartum Haemorrhage Treatment Device Market
8.2.4.4.1 Spain Postpartum Haemorrhage Treatment Device Market by Product
8.2.4.5 United Kingdom Postpartum Haemorrhage Treatment Device Market
8.2.4.5.1 United Kingdom Postpartum Haemorrhage Treatment Device Market by Product
8.2.4.6 Rest of Europe Postpartum Haemorrhage Treatment Device Market
8.2.4.6.1 Rest of Europe Postpartum Haemorrhage Treatment Device Market by Product
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Postpartum Haemorrhage Treatment Device Market Overview
8.3.2 Asia-Pacific Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis
8.3.3 Asia-Pacific Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis - By Product
8.3.4 Asia-Pacific Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Postpartum Haemorrhage Treatment Device Market
8.3.4.1.1 Australia Postpartum Haemorrhage Treatment Device Market by Product
8.3.4.2 China Postpartum Haemorrhage Treatment Device Market
8.3.4.2.1 China Postpartum Haemorrhage Treatment Device Market by Product
8.3.4.3 India Postpartum Haemorrhage Treatment Device Market
8.3.4.3.1 India Postpartum Haemorrhage Treatment Device Market by Product
8.3.4.4 Japan Postpartum Haemorrhage Treatment Device Market
8.3.4.4.1 Japan Postpartum Haemorrhage Treatment Device Market by Product
8.3.4.5 South Korea Postpartum Haemorrhage Treatment Device Market
8.3.4.5.1 South Korea Postpartum Haemorrhage Treatment Device Market by Product
8.3.4.6 Rest of Asia-Pacific Postpartum Haemorrhage Treatment Device Market
8.3.4.6.1 Rest of Asia-Pacific Postpartum Haemorrhage Treatment Device Market by Product
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Postpartum Haemorrhage Treatment Device Market Overview
8.4.2 Middle East and Africa Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis
8.4.3 Middle East and Africa Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis - By Product
8.4.4 Middle East and Africa Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Postpartum Haemorrhage Treatment Device Market
8.4.4.1.1 South Africa Postpartum Haemorrhage Treatment Device Market by Product
8.4.4.2 Saudi Arabia Postpartum Haemorrhage Treatment Device Market
8.4.4.2.1 Saudi Arabia Postpartum Haemorrhage Treatment Device Market by Product
8.4.4.3 U.A.E Postpartum Haemorrhage Treatment Device Market
8.4.4.3.1 U.A.E Postpartum Haemorrhage Treatment Device Market by Product
8.4.4.4 Rest of Middle East and Africa Postpartum Haemorrhage Treatment Device Market
8.4.4.4.1 Rest of Middle East and Africa Postpartum Haemorrhage Treatment Device Market by Product
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Postpartum Haemorrhage Treatment Device Market Overview
8.5.2 South and Central America Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis
8.5.3 South and Central America Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis - By Product
8.5.4 South and Central America Postpartum Haemorrhage Treatment Device Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Postpartum Haemorrhage Treatment Device Market
8.5.4.1.1 Brazil Postpartum Haemorrhage Treatment Device Market by Product
8.5.4.2 Argentina Postpartum Haemorrhage Treatment Device Market
8.5.4.2.1 Argentina Postpartum Haemorrhage Treatment Device Market by Product
8.5.4.3 Rest of South and Central America Postpartum Haemorrhage Treatment Device Market
8.5.4.3.1 Rest of South and Central America Postpartum Haemorrhage Treatment Device Market by Product
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL POSTPARTUM HAEMORRHAGE TREATMENT DEVICE MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of the World
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. POSTPARTUM HAEMORRHAGE TREATMENT DEVICE MARKET, KEY COMPANY PROFILES
11.1. COOK MEDICAL
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. UTAH MEDICAL PRODUCTS, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BACTIGUARD
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ALYDIA HEALTH
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. STERIMED GROUP
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ANGIPLAST
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SARA HEALTH CARE
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BOEN HEALTHCARE CO., LTD
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. MCKESSON MEDICAL-SURGICAL INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Cook Medical
2. BD
3. Utah Medical Products, Inc.
4. BACTIGUARD
5. Alydia Health
6. Sterimed Group
7. Angiplast
8. Sara Health Care
9. Boen Healthcare Co., Ltd
10. McKesson Medical-Surgical Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For